BBNS logo

The Latest Headlines at BBNS

Image about 26,127 Target Corporation $TGT Shares Sold by Pzena Investment Management LLC

26,127 Target Corporation $TGT Shares Sold by Pzena Investment Management LLC

Pzena Investment Management LLC reduced its stake in Target Corporation (NYSE:TGT – Free Report) by 7.0% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 347,376 shares of the retailer’s... More of this article »
Image about Strategent Financial LLC Purchases 10,641 Shares of Dimensional U.S. Small Cap ETF $DFAS

Strategent Financial LLC Purchases 10,641 Shares of Dimensional U.S. Small Cap ETF $DFAS

Strategent Financial LLC grew its position in Dimensional U.S. Small Cap ETF (NYSEARCA:DFAS – Free Report) by 16.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.... More of this article »
Image about Vanguard Short-Term Corporate Bond ETF $VCSH Holdings Lifted by Guardian Wealth Management Inc.

Vanguard Short-Term Corporate Bond ETF $VCSH Holdings Lifted by Guardian Wealth Management Inc.

Guardian Wealth Management Inc. boosted its position in Vanguard Short-Term Corporate Bond ETF (NASDAQ:VCSH – Free Report) by 12.3% in the third quarter, according to its most recent filing with the SEC. The institutional investor... More of this article »
Image about The Hackett Group, Inc. (HCKT) To Go Ex-Dividend on December 24th

The Hackett Group, Inc. (HCKT) To Go Ex-Dividend on December 24th

The Hackett Group, Inc. (NASDAQ:HCKT – Get Free Report) announced a quarterly dividend on Tuesday, November 3rd. Shareholders of record on Thursday, December 24th will be given a dividend of $0.12 per share by the business services... More of this article »
Image about Retension Pharmaceuticals (NASDAQ:RTSN) Now Covered by Leerink Partners

Retension Pharmaceuticals (NASDAQ:RTSN) Now Covered by Leerink Partners

Leerink Partners initiated coverage on shares of Retension Pharmaceuticals (NASDAQ:RTSN – Free Report) in a report published on Tuesday,Zacks reports. The brokerage issued a strong-buy rating on the stock. RTSN has been the subject... More of this article »
Image about First American Financial Corporation (FAF) to Issue Quarterly Dividend of $0.61 on December 15th

First American Financial Corporation (FAF) to Issue Quarterly Dividend of $0.61 on December 15th

First American Financial Corporation (NYSE:FAF – Get Free Report) declared a quarterly dividend on Tuesday, November 3rd. Investors of record on Tuesday, December 8th will be given a dividend of $0.61 per share by the insurance... More of this article »
Image about Phibro Animal Health Corporation (PAHC) to Distribute Quarterly Dividend of $0.12 on December 16th

Phibro Animal Health Corporation (PAHC) to Distribute Quarterly Dividend of $0.12 on December 16th

Phibro Animal Health Corporation (NASDAQ:PAHC – Get Free Report) declared a quarterly dividend on Tuesday, November 3rd. Investors of record on Wednesday, November 25th will be paid a dividend of $0.12 per share on Wednesday,... More of this article »
Image about AdvanSix (NYSE:ASIX) to Issue Quarterly Dividend of $0.16

AdvanSix (NYSE:ASIX) to Issue Quarterly Dividend of $0.16

AdvanSix (NYSE:ASIX – Get Free Report) announced a quarterly dividend on Wednesday, November 4th. Shareholders of record on Tuesday, November 17th will be given a dividend of $0.16 per share on Tuesday, December 1st. This represents... More of this article »
Image about Financial Comparison: Mogo (MOGO) vs. The Competition

Financial Comparison: Mogo (MOGO) vs. The Competition

Mogo (NASDAQ:MOGO – Get Free Report) is one of 271 public companies in the “IT Services” industry, but how does it weigh in compared to its peers? We will compare Mogo to similar businesses based on the strength of... More of this article »
Image about Contrasting Marker Therapeutics (NASDAQ:MRKR) and Madrigal Pharmaceuticals (NASDAQ:MDGL)

Contrasting Marker Therapeutics (NASDAQ:MRKR) and Madrigal Pharmaceuticals (NASDAQ:MDGL)

Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Free Report) and Marker Therapeutics (NASDAQ:MRKR – Get Free Report) are both healthcare companies, but which is the better business? We will compare the two businesses based... More of this article »
Image about United Therapeutics (NASDAQ:UTHR) Announces Earnings Results, Misses Expectations By $0.30 EPS

United Therapeutics (NASDAQ:UTHR) Announces Earnings Results, Misses Expectations By $0.30 EPS

United Therapeutics (NASDAQ:UTHR – Get Free Report) issued its quarterly earnings results on Wednesday. The biotechnology company reported $5.71 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates... More of this article »
Image about Tennant (NYSE:TNC) Issues FY 2026 Earnings Guidance

Tennant (NYSE:TNC) Issues FY 2026 Earnings Guidance

Tennant (NYSE:TNC – Get Free Report) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 3.800-4.450 for the period, compared to the consensus estimate of... More of this article »
Image about DoorDash (DASH) – Investment Analysts’ Weekly Ratings Changes

DoorDash (DASH) – Investment Analysts’ Weekly Ratings Changes

Several analysts have recently updated their ratings and price targets for DoorDash (NASDAQ: DASH): 10/30/2026 – DoorDash had its “outperform” rating reaffirmed by Sanford C. Bernstein. They now have a $250.00 price... More of this article »
Image about J & J Snack Foods (NASDAQ:JJSF) Stock Moved Down to Strong Sell by Zacks Research

J & J Snack Foods (NASDAQ:JJSF) Stock Moved Down to Strong Sell by Zacks Research

Zacks Research downgraded shares of J & J Snack Foods (NASDAQ:JJSF – Free Report) from a hold rating to a strong sell rating in a research note published on Tuesday morning,Zacks reports. JJSF has been the topic of a number... More of this article »
Image about Zacks Research Upgrades Salesforce (NYSE:CRM) to “Strong-Buy”

Zacks Research Upgrades Salesforce (NYSE:CRM) to “Strong-Buy”

Salesforce (NYSE:CRM – Get Free Report) was upgraded by Zacks Research from a “hold” rating to a “strong-buy” rating in a research report issued to clients and investors on Tuesday, Zacks reports. Several... More of this article »